If you are new to TikTikTalk ? Your first verification mail might be in your spam folder.Check there and move it to your inbox to complete registration or account verification process..
إعلان مُمول
sociofans

Cell & Gene Therapy Manufacturing Services Market worth $11.5 Billion

0
1كيلو بايت

The global cell & gene therapy manufacturing services market is expected to reach USD 11.5 billion by 2027, growing at a CAGR of 17.5% from 2022 to 2027. Growing prevalence of cancer and other other diseases, the surge in pharmaceutical R&D spending along with partnerships and agreements between pharmaceutical companies and CDMOs are some of the factors driving the market growth. On the contrary, the significant operational costs associated with cell and gene therapy manufacturing is expected to negatively impact the cell & gene therapy manufacturing market during the forecast period.

Request for Free Sample Report

Key Takeaways

  • The global cell & gene therapy manufacturing services market is expected to reach USD 11.5 billion by 2027, growing at a CAGR of 17.5% from 2022 to 2027.
  • The cell therapy segment dominated the cell & gene therapy manufacturing services market in 2021.
  • North America was the largest regional market for cell & gene therapy manufacturing services market in 2021.
  • Lonza (Switzerland), Catalent (US), Thermo Fisher Scientific (US), Charles River Laboratories (US), WuXi AppTec (China), Merck KGaA (Germany), Takara Bio Inc. (Japan), Oxford Biomedica (UK), Cell and Gene Therapy Catapult (UK) are some of the key players in the cell & gene therapy manufacturing services market.

Market Drivers

  • Growing prevalence of cancer and other other diseases
  • Surge in pharmaceutical R&D spending
  • Partnerships and agreements between pharmaceutical companies and CDMOs
  • Expansion of cell and gene therapy manufacturing capacities by CDMOs

Market Restraints

  • Significant operational costs associated with cell and gene therapy manufacturing
  • Stringent regulatory requirements
  • Lack of skilled professionals

Market Opportunities

  • Increasing demand for cell and gene therapies
  • Growing number of clinical trials for cell and gene therapies
  • Development of new cell and gene therapy technologies

Market Trends

  • Increasing adoption of cell and gene therapy manufacturing services by pharmaceutical and biotechnology companies
  • Growing focus on partnerships and collaborations between pharmaceutical companies and CDMOs
  • Expansion of cell and gene therapy manufacturing capacities by CDMOs

Geographical Analysis

  • North America was the largest regional market for cell & gene therapy manufacturing services market in 2021.
  • Europe is expected to be the second-largest market for cell & gene therapy manufacturing services market during the forecast period.
  • Asia Pacific is expected to be the fastest-growing market for cell & gene therapy manufacturing services market during the forecast period.

Company Profiles

  • Lonza (Switzerland)
  • Catalent (US)
  • Thermo Fisher Scientific (US)
  • Charles River Laboratories (US)
  • WuXi AppTec (China)
  • Merck KGaA (Germany)
  • Takara Bio Inc. (Japan)
  • Oxford Biomedica (UK)
  • Cell and Gene Therapy Catapult (UK)
  • Genezen (US)
  • FUJIFILM Holdings Corporation (Japan)
  • Nikon Corporation (Japan)
  • The Discovery Labs LLC (US)
  • RoslinCT (Scotland)
  • JRS Pharma (Germany)
  • FinVector (Finland)
  • ABL, Inc. (US)
  • Resilience (US)
  • BioCentriq (US)
  • Porton Advanced Solutions (China)
  • Andelyn Biosciences (US)
  • Forge Biologics (US)
  • Vibalogics (US)
  • Anemocyte Srl (Italy)
  • ElevateBio (US)

Speak to Analyst

Recent Developments

  • In 2021, Charles River Laboratories acquired a cell & gene therapy CDMO—Cognate BioServices—to increase its cell and gene therapy manufacturing capabilities.
  • In 2021, Thermo Fisher Scientific acquired Henogen S.A., Novasep's viral vector manufacturing business in Belgium, for approximately USD 859.7 million. This acquisition will increase its presence in the cell & gene therapy manufacturing therapy market.
  • In 2019, Thermo Fisher Scientific acquired Brammer Bio, a company engaged in viral vector manufacturing for gene and cell therapies, for USD 1.7 billion.

Top 10 Companies in the Tissue Diagnostics Market
Top 10 Companies in Human Capital Management Market
Top 10 Companies Leading the Patient Engagement Solutions Market
Top 10 Companies in the Blood Collection Devices Market

إعلان مُمول
إعلان مُمول
البحث
إعلان مُمول
الأقسام
إقرأ المزيد
أخرى
Artificial Intelligence In Military Market Growth and Growth Report 2023
Artificial Intelligence In Military Market Overview: The Artificial Intelligence In...
بواسطة emilycooper 2023-10-25 15:17:59 0 3كيلو بايت
Networking
optical connectivity solutions Market Size, Trends, Scope and Growth Analysis to 2033
According to the Regional Research Reports, the Global Optical Connectivity Solutions...
بواسطة Nit234 2023-07-08 11:47:13 0 4كيلو بايت
أخرى
 Sterile Medical Packaging market size: top companies, regional analysis & development
The Sterile Medical Packaging market size research looks into how vendors differ...
بواسطة ramos 2023-11-02 06:21:01 0 3كيلو بايت
Networking
Outdoor Sports Shoes Market Set to Witness Explosive Growth by 2033
According to the Regional Research Reports, the global outdoor sports shoes market size...
بواسطة Nit234 2023-10-18 08:52:22 0 2كيلو بايت
أخرى
Modular Data Center Market size is projected to reach USD 59,971.0 million by 2027
The global modular data center market is registering a CAGR of 18.70%., and was valued...
بواسطة marketstatsvillegroup 2024-01-09 08:40:28 0 2كيلو بايت
إعلان مُمول